Clinical Trial Services Company VeraSci Joins Forces with ActiGraph to Expand Wearables Use in Clinical Trials

VeraSci, a global clinical research company announced it has partnered with ActiGraph, a leading...

Photo credit: VeraSci

VeraSci, a global clinical research company announced it has partnered with ActiGraph, a leading provider of medical-grade wearable activity and sleep monitoring devices. VeraSci's Innovation Lab will be incorporating ActiGraph's CentrePoint Insight Watch into an NIH-funded study examining the relationship between real-time measurements of gait and actigraphy collected by industry-grade wearables and established cognitive and functional endpoints that are sensitive to decline early in the Alzheimer's disease continuum.

Read more: Koneksa Publishes Data Assessing Wearable Devices for Clinical Trial Participants

Preliminary data have indicated a correlation between remotely captured gait and actigraphy measures and established cognition and function measures. These data suggest that wearables can provide meaningful information regarding cognitive health and may ultimately contribute to continuous assessment of cognition and function in clinical trials, says a press release.

“Wearables present an incredible opportunity to gather data in ways that haven't been feasible before. We can gather information directly while patients are engaged in their daily lives,” says VeraSci CEO Dr. Rich Keefe, “Our partnership with ActiGraph advances our commitment to pairing scientific knowledge with cutting-edge technology to improve the tools and measurements available in clinical trials.”

“This partnership between ActiGraph and VeraSci provides an exciting opportunity to better understand the relationship between real-world physical behavior, function, and cognition,” said Matt Biggs, ActiGraph's Head of Business Operations. “We believe that these types of collaborations will help to jumpstart the creation of novel digital endpoints for global health communities.”

The research was supported by the National Institute on Aging of the National Institutes of Health Small Business Innovation Research (SBIR) program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Read more: Spark Biomedical Launches Clinical Trial to Validate its Auricular Neurostimulation Device for Opioid Withdrawal Relief

About VeraSci:

VeraSci brings scientific expertise, strategic innovation, and unwavering commitment to each project, helping clients worldwide develop novel therapies.

About ActiGraph:

ActiGraph's FDA-cleared wearable actigraphy monitors and robust analytics platform have been widely used to quantify human movement in academic and population health research for nearly two decades. In recent years, the company's monitoring solutions have been steadily adopted by pharmaceutical and life sciences organizations seeking to capture real-world objective outcomes related to physical activity, mobility, and sleep behavior for patients enrolled in clinical trials.

Sam Draper
January 20, 2021

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

AI-Powered Stethoscope Detects Heart Disease

Eko Health is rolling out its AI-powered stethoscopes to primary care practices across the U.K.

Firstbeat Introduces Firstbeat Sports Sensor and Live App with Movesense to Improve Coaching

Firstbeat Sports has launched its next generation Firstbeat Sports Sensor and Live app.

Non-Invasive Bladder Control Therapy Device

The Vivally wearable system by Avation Medical demonstrated reductions in Urge Urinary Incontinence. Unveils Contactless Blood Pressure Monitoring System announced the availability of Blood Pressure measurements added to its Health Date Platform
Discover more